STELLARIS PHARMACEUTICALS ApS: Financial statements 2020
CVR: 34708215
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
STELLARIS PHARMACEUTICALS ApS (CVR 34708215) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -100,936 and a net result of DKK -78,835 compared with DKK -57,616 the year before. Equity in the 2020 report amounted to DKK -355,669.
- Gross Profit
- DKK -100,936
- Profit/Loss
- DKK -78,835
- Equity
- DKK -355,669
- Total Assets
- DKK 18,912
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -101 t. | -79 t. | -356 t. | - |
| 2019 | - | -71 t. | -58 t. | -277 t. | - |
| 2018 | - | -70 t. | -113 t. | -219 t. | 0 |
| 2017 | - | -45 t. | -78 t. | -107 t. | 0 |
| 2016 | - | - | -118 t. | -575 t. | - |
Official annual report
How creditworthy is STELLARIS PHARMACEUTICALS ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
STELLARIS PHARMACEUTICALS ApS has published its annual report for 2019. Gross profit came to DKK -70,772, and the net result was DKK -57,616.
About STELLARIS PHARMACEUTICALS ApS
STELLARIS PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2012. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Birgit Ter-Borch Gram Lilienfeldt Schjoldager. The company is owned by Ranoda Holding ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -475,262 and a net result of DKK -594,882 compared with DKK -486,941 the year before. Equity in the 2025 report amounted to DKK -3,565,816.